Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Adagene Suzhou Limited
Deal Size : Undisclosed
Deal Type : Collaboration
Adagene Announces Strategic Collaboration Agreement with Tanabe Research Laboratories
Details : Under the terms of this collaboration, TRL will use Adagene’s SAFEbody™ technology platform to generate a masked antibody in combination with the cytotoxic payload technologies used at TRL, for the development of an ADC against a solid tumor target.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 06, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Adagene Suzhou Limited
Deal Size : Undisclosed
Deal Type : Collaboration